# Avalon Holdings Corp: overview

AWX · NYSE · CIK 1061069 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/awx.md) · [Financials](/companies/awx/financials.md) · [Filings](/companies/awx/filings.md) · [Insiders](/companies/awx/insiders.md)

Latest reported revenue: [$20.9m](/filings/0001437749-26-026609.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001437749-26-026609).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [24.2](/filings/0001437749-25-033887.md) | [17.6 d](/filings/0001437749-26-009091.md) | [16.1](/filings/0001437749-26-014934.md) | [20.3](/filings/0001437749-26-026609.md) | [25.7](/filings/0001437749-25-033887.md) | [21.5 d](/filings/0001437749-26-009091.md) | [17.7](/filings/0001437749-26-014934.md) | [20.9](/filings/0001437749-26-026609.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [9.4%](/filings/0001437749-25-033887.md) | [(0.8%) d](/filings/0001437749-26-009091.md) | [(7.2%)](/filings/0001437749-26-014934.md) | [3.7%](/filings/0001437749-26-026609.md) | [9.1%](/filings/0001437749-25-033887.md) | [0.4% d](/filings/0001437749-26-009091.md) | [(4.2%)](/filings/0001437749-26-014934.md) | [6.5%](/filings/0001437749-26-026609.md) |
| Net margin | % | [7.6%](/filings/0001437749-25-033887.md) | [(2.8%) d](/filings/0001437749-26-009091.md) | [(9.3%)](/filings/0001437749-26-014934.md) | [1.4%](/filings/0001437749-26-026609.md) | [7.4%](/filings/0001437749-25-033887.md) | [(1.7%) d](/filings/0001437749-26-009091.md) | [(7.0%)](/filings/0001437749-26-014934.md) | [4.2%](/filings/0001437749-26-026609.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [(0.7) d](/filings/0001437749-25-033887.md) | [(1.1) d](/filings/0001437749-26-009091.md) | [(1.4)](/filings/0001437749-26-014934.md) | [2.7 d](/filings/0001437749-26-026609.md) | [0.9 d](/filings/0001437749-25-033887.md) | [(0.2) d](/filings/0001437749-26-009091.md) | [(1.8)](/filings/0001437749-26-014934.md) | [2.4 d](/filings/0001437749-26-026609.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [70.4](/filings/0001437749-23-007669.md) | [81.2](/filings/0001437749-24-008877.md) | [80.9](/filings/0001437749-25-008584.md) | [83.8](/filings/0001437749-26-009091.md) | [83.5](/filings/0001437749-26-009091.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [0.8%](/filings/0001437749-23-007669.md) | [0.4%](/filings/0001437749-24-008877.md) | [0.1%](/filings/0001437749-25-008584.md) | [3.7%](/filings/0001437749-26-009091.md) | [2.4%](/filings/0001437749-26-009091.md) |
| Net margin | % | [2.8%](/filings/0001437749-23-007669.md) | [(0.7%)](/filings/0001437749-24-008877.md) | [(2.2%)](/filings/0001437749-25-008584.md) | [1.6%](/filings/0001437749-26-009091.md) | [0.4%](/filings/0001437749-26-009091.md) |
| Diluted EPS | $ per share | [0.50](/filings/0001437749-23-007669.md) | [(0.15)](/filings/0001437749-23-007669.md) | not reported | not reported | not reported |
| Free cash flow | $m | [(2.1)](/filings/0001437749-23-007669.md) | [(4.1)](/filings/0001437749-24-008877.md) | [(1.5)](/filings/0001437749-25-008584.md) | [1.1](/filings/0001437749-26-009091.md) | [2.1](/filings/0001437749-26-009091.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/awx/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $189.0k | 75,897 |  | Unchanged |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $176.3k | 70,810 |  | Reduced −5,172 |
| [WITTENBERG INVESTMENT MANAGEMENT, INC.](/funds/1697790.md) | 2026-06-30 | $91.6k | 36,784 |  | Unchanged |
| [RAFFLES ASSOCIATES LP](/funds/1169581.md) | 2026-06-30 | $64.7k | 25,968 |  | Added +754 |
| [RAFFLES ASSOCIATES LP](/funds/1169581.md) | 2026-06-30 | $64.7k | 25,968 |  | Added +754 |
| [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $51.8k | 20,800 |  | Unchanged |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $44.5k | 17,855 |  | New +17,855 |
| [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $41.2k | 16,538 |  | Unchanged |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $26.5k | 10,649 |  | Unchanged |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $19.3k | 7,743 |  | Unchanged |

## Recent filings

[All 258 filings](/companies/awx/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 13:52 ET | [8-K](/filings/0001437749-26-032511.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-032511 |
| 2026-08-07 | 21:02 ET | [10-Q](/filings/0001437749-26-026609.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026609 |
| 2026-05-06 | 12:51 ET | [8-K](/filings/0001437749-26-015034.md) | 5.07 Shareholder vote results | 0001437749-26-015034 |
| 2026-05-05 | 21:02 ET | [10-Q](/filings/0001437749-26-014934.md) | Quarterly report, period 2026-03-31 | 0001437749-26-014934 |
| 2026-03-20 | 21:01 ET | [DEF 14A](/filings/0001437749-26-009261.md) | Proxy statement, period 2026-05-05 | 0001437749-26-009261 |
| 2026-03-19 | 21:01 ET | [10-K](/filings/0001437749-26-009091.md) | Annual report, period 2025-12-31 | 0001437749-26-009091 |
| 2025-11-07 | 22:02 ET | [10-Q](/filings/0001437749-25-033887.md) | Quarterly report, period 2025-09-30 | 0001437749-25-033887 |
| 2025-09-24 | 19:44 ET | [8-K](/filings/0001437749-25-029797.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-029797 |
| 2025-08-08 | 21:05 ET | [10-Q](/filings/0001437749-25-025765.md) | Quarterly report, period 2025-06-30 | 0001437749-25-025765 |
| 2025-07-10 | 12:56 ET | [SCHEDULE 13D/A](/filings/0002076083-25-000002.md) | Ownership report, active investor, amended | 0002076083-25-000002 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-009091.md), filed Mar 19, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/87db5859-7a15-437c-9249-e598735e2662)

## About the filer

- CIK: 1061069
- Tickers: AWX
- Exchange: NYSE
- SIC code: 4953 Refuse Systems
- State of incorporation: OH
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.
